Search
Search Results
##search.searchResults.foundPlural##
-
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
2937PDF: 1352HTML: 161 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3255PDF: 1022HTML: 2032 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2390PDF: 844HTML: 2156New table Chinese children with APL: 163 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3314PDF: 1257HTML: 8123 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2091PDF: 1904HTML: 350 -
PEDIATRIC TUBERCULOSIS IN THE NORTH SARDINIA
2492PDF: 873HTML: 2392 -
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE IN EGYPTIAN CHILDREN
1820PDF: 850HTML: 1153Cover: 184 -
DIAGNOSTIC ACCURACY OF CLINICAL TOOL ‘STOPS’ AND SERUM PROCALCITONIN FOR OPTIMIZING ANTIBIOTIC THERAPY IN NEONATAL SEPSIS STOPS and procalcitonin for optimizing antibiotics in neonatal sepsis
1669PDF: 592HTML: 404 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
1022PDF: 704HTML: 226 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3375PDF: 1486HTML: 4016 -
-
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
657PDF: 253Html: 33 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2277PDF: 903HTML: 2099 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2120PDF: 667HTML: 281 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3718PDF: 1245HTML: 3908Untitled: 229Untitled: 266 -
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2402PDF: 945HTML: 324 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4002Suppl. Files: 1140PDF: 1086Html: 180 -
SICKLE CELL ANAEMIA AND MALARIA
11551PDF: 7133HTML: 23917Figures Malaria and SCK: 217 -
-
ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes
1428PDF: 1241HTML: 486 -
ASSESSMENT OF DIAGNOSTIC TECHNIQUES OF URINARY TUBERCULOSIS
2035PDF: 785HTML: 2346Untitled: 217 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2284PDF: 619Suppl. Files: 286HTML: 176 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8045PDF: 4244HTML: 7510 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2057PDF: 846HTML: 259 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2429PDF: 1016HTML: 163Suppl. Files: 516 -
-
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5189PDF: 1337HTML: 2755Cover letter: 200 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2870PDF: 963HTML: 7348 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2530PDF: 946HTML: 306







